rs606231367
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_001853.4(COL9A3):c.148-1G>A variant causes a splice acceptor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001853.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL9A3 | ENST00000649368.1 | c.148-1G>A | splice_acceptor_variant, intron_variant | Intron 2 of 31 | NM_001853.4 | ENSP00000496793.1 | ||||
COL9A3 | ENST00000452372.2 | c.37-1G>A | splice_acceptor_variant, intron_variant | Intron 1 of 11 | 5 | ENSP00000394280.1 | ||||
COL9A3 | ENST00000477612.5 | n.144-1G>A | splice_acceptor_variant, intron_variant | Intron 2 of 11 | 3 | |||||
COL9A3 | ENST00000489045.5 | n.194-1G>A | splice_acceptor_variant, intron_variant | Intron 1 of 13 | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
This sequence change affects an acceptor splice site in intron 2 of the COL9A3 gene. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), however it is unknown whether splice variants in this region will result in a loss of function. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with autosomal dominant epiphyseal dysplasia (PMID: 10655510, 10678658). It has also been observed to segregate with disease in related individuals. This variant is also known as G-1IVS2>A, (IVS2,G-A,-1). ClinVar contains an entry for this variant (Variation ID: 17141). Studies have shown that disruption of this splice site results in skipping of exon 3, but is expected to preserve the integrity of the reading-frame (PMID: 10655510, 10678658). For these reasons, this variant has been classified as Pathogenic. -
Epiphyseal dysplasia, multiple, 3 Pathogenic:1
PM2_Supporting+PVS1_Strong+PS4_Supporting+PP4+PP1_Strong -
Epiphyseal dysplasia, multiple, 3, with myopathy Pathogenic:1
- -
COL9A3-related disorder Pathogenic:1
The COL9A3 c.148-1G>A variant is predicted to disrupt the AG splice acceptor site and interfere with normal splicing. This variant was reported to segregate with disease in two families with multiple epiphyseal dysplasia (Lohiniva et al. 2000. PubMed ID: 10678658; Bönnemann et al. 2000. PubMed ID: 10655510). This variant has not been reported in a large population database, indicating this variant is rare. Variants that disrupt the consensus splice acceptor site in COL9A3 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at